Sen. Warren Presses FTC to Scrutinize Two Pending Pharma Mergers

By PacConAdmin | January 29, 2023

Sen. Elizabeth Warren (D-Mass.) has asked the Federal Trade Commission (FTC) to take a hard look at two pending pharmaceutical mergers she believes could impact drug prices.
Source: Drug Industry Daily

Posted in Drug Industry Daily